TP63 ‐rearranged ALK ‐negative anaplastic large‐cell lymphoma post‐transplant lymphoproliferative disorder: the first report of an aggressive entity
Internal Medicine Journal · 2026-03 · 56 (3) · 499-501
DOI: 10.1111/imj.70331 ↗At a glance
Leserbrief in Internal Medicine Journal, published online on 2026-03-05. Written by Frances Zhao and 3 co-authors. Institution: Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. 12 references.
Abstract (original language)
Není k dispozici žádný abstrakt.
Authors and institutions
- Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
- School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
ORCID profiles: Frances Zhao
Cite
APA
Zhao, F., Cox, J., Mollee, P., & Hapgood, G. (2026). TP63 ‐rearranged ALK ‐negative anaplastic large‐cell lymphoma post‐transplant lymphoproliferative disorder: the first report of an aggressive entity. Internal Medicine Journal, 56(3), 499-501. https://doi.org/10.1111/imj.70331
Vancouver
Zhao F, Cox J, Mollee P, Hapgood G. TP63 ‐rearranged ALK ‐negative anaplastic large‐cell lymphoma post‐transplant lymphoproliferative disorder: the first report of an aggressive entity. Internal Medicine Journal. 2026;56(3):499-501. doi:10.1111/imj.70331
BibTeX
@article{Zhao2026,
author = {Zhao, Frances and Cox, Jenna and Mollee, Peter and Hapgood, Greg},
title = {TP63 ‐rearranged ALK ‐negative anaplastic large‐cell lymphoma post‐transplant lymphoproliferative disorder: the first report of an aggressive entity},
journal = {Internal Medicine Journal},
year = {2026},
volume = {56},
number = {3},
pages = {499--501},
doi = {10.1111/imj.70331}
}
EUVIMED